Resultaten

…insights, we aim to develop diagnostic tools and therapeutic strategies that target these sugar changes. Our research spans from target identification/validation and design of novel immunotherapeutics to preclinical proof-of-efficacy studies…

The patients were followed up from 6 months to 14.3 years (mean, 6.9 years). RESULTS: There were 34 women and 27 men (1.26:1 ratio; age range, 6 to 46 years;…

…Sloand, E.M., et al. Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy. JCO 2008;26:2505. Stahl, M, et al. The use of immunosuppressive therapy in MDS:…

…Presentatie https://www.youtube.com/watch?v=VK-TouB1dPw Presentatie landelijke patiëntendag, Wilfried Roeloffzen Literatuurlijst Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol…

…of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer (EORTC). Blood 2007, 110, 479-84. Marchi,…

…A similar level of heterogeneity is seen within the tumor microenvironment in the bone marrow of patients, and we aim to functionally characterize stromal cells and various innate and adaptive…

…3503 RD Utrecht Tel. (030) 760 34 60 E-mail: secretariaat@hematon.nl www.hematon.nl   Thalassemie en sikkelcelanemie Oscar Nederland Postbus 4 3980 CA Bunnik www.oscarnederland.nl   Trombose en longembolie Op de onderstaande…

…onder andere af van de symptomatologie, comorbiditeit, gebruik van antistolling, ingrepen in de nabije toekomst en leeftijd. In de praktijk wordt vaak een grens van 30×109/L of lager aangehouden, al…

Deze print is 24 uur geldig na het aanmaken. Aangemaakt op: 27-9-2024, 6:19